1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Budgetary Impact of Medicinal Therapies for Rare Diseases in Bulgaria
(
- Contribution to journal › Article
-
Mark
Access to orphan drugs - comparison across Balkan countries
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Transposition and implementation of EU rare disease policy in Eastern Europe
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
(
- Contribution to journal › Article
-
Mark
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
(
- Contribution to journal › Article